{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T06:41:14Z","timestamp":1740120074268,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T00:00:00Z","timestamp":1564012800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T00:00:00Z","timestamp":1564012800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007449","name":"the Takeda Science Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Intramural Research Fund of the National Cerebral and Cardiovascular Center of Japan","award":["grants #23-6-8","#25-6-8","#27-6-27"],"award-info":[{"award-number":["grants #23-6-8","#25-6-8","#27-6-27"]}]},{"name":"Japan Society for the Promotion of Science KAKENHI grant","award":["#JP18K09277"],"award-info":[{"award-number":["#JP18K09277"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s12185-019-02712-z","type":"journal-article","created":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T11:02:36Z","timestamp":1564052556000},"page":"550-558","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A less-intensive anticoagulation protocol of therapeutic unfractionated heparin administration for pregnant patients"],"prefix":"10.1007","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4660-2782","authenticated-orcid":false,"given":"Reiko","family":"Neki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mana","family":"Mitsuguro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazufumi","family":"Ida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takekazu","family":"Miyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chizuko","family":"Kamiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Iwanaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Yoshimatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,25]]},"reference":[{"key":"2712_CR1","doi-asserted-by":"publisher","first-page":"e691S","DOI":"10.1378\/chest.11-2300","volume":"141","author":"SM Bates","year":"2012","unstructured":"Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos AM, Vandvik PO, et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141:e691S\u2013736S.","journal-title":"Chest"},{"key":"2712_CR2","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/0002-9343(80)90181-3","volume":"68","author":"JG Hall","year":"1980","unstructured":"Hall JG, Pauli RM, Wilson KM. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med. 1980;68:122\u201340.","journal-title":"Am J Med"},{"key":"2712_CR3","first-page":"673","volume":"57","author":"MJ Harrod","year":"1981","unstructured":"Harrod MJ, Sherrod PS. Warfarin embryopathy in siblings. Obstet Gynecol. 1981;57:673\u20136.","journal-title":"Obstet Gynecol"},{"key":"2712_CR4","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/S0140-6736(86)91421-2","volume":"1","author":"A Morabia","year":"1986","unstructured":"Morabia A. Heparin doses and major bleedings. Lancet. 1986;1:1278\u20139.","journal-title":"Lancet"},{"key":"2712_CR5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1001\/archinte.1994.00420010073009","volume":"154","author":"MN Levine","year":"1994","unstructured":"Levine MN, Hirsh J, Gent M, Turpie AG, Cruickshank M, Weitz J, et al. A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin. Arch Intern Med. 1994;154:49\u201356.","journal-title":"Arch Intern Med"},{"key":"2712_CR6","doi-asserted-by":"publisher","first-page":"e24S","DOI":"10.1378\/chest.11-2291","volume":"141","author":"DA Garcia","year":"2012","unstructured":"Garcia DA, Baglin TP, Weitz JI, Samama MM, American College of Chest P. Parenteral anticoagulants: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141:e24S\u201343S.","journal-title":"Chest"},{"key":"2712_CR7","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1056\/NEJM197208172870703","volume":"287","author":"D Basu","year":"1972","unstructured":"Basu D, Gallus A, Hirsh J, Cade J. A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. N Engl J Med. 1972;287:324\u20137.","journal-title":"N Engl J Med"},{"key":"2712_CR8","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1093\/eurheartj\/ehr218","volume":"32","author":"V Regitz-Zagrosek","year":"2011","unstructured":"European Society of Gynecology, Association for European Paediatric Cardiology, German Society for Gender Medicine, Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, Cifkova R, Ferreira R, et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the task force on the management of cardiovascular diseases during pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2011;32:3147\u201397.","journal-title":"Eur Heart J"},{"key":"2712_CR9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1024\/0301-1526\/a000504","volume":"45","author":"B Linnemann","year":"2016","unstructured":"Linnemann B, Scholz U, Rott H, Halimeh S, Zotz R, Gerhardt A, et al. Treatment of pregnancy-associated venous thromboembolism-position paper from the Working Group in Women\u2019s Health of the Society of Thrombosis and Haemostasis (GTH). Vasa. 2016;45:103\u201318.","journal-title":"Vasa"},{"key":"2712_CR10","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1055\/s-0038-1661167","volume":"52","author":"Y Stirling","year":"1984","unstructured":"Stirling Y, Woolf L, North WR, Seghatchian MJ, Meade TW. Haemostasis in normal pregnancy. Thromb Haemost. 1984;52:176\u201382.","journal-title":"Thromb Haemost"},{"key":"2712_CR11","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1160\/TH09-10-0704","volume":"103","author":"PB Szecsi","year":"2010","unstructured":"Szecsi PB, Jorgensen M, Klajnbard A, Andersen MR, Colov NP, Stender S. Haemostatic reference intervals in pregnancy. Thromb Haemost. 2010;103:718\u201327.","journal-title":"Thromb Haemost"},{"key":"2712_CR12","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s12185-014-1702-z","volume":"101","author":"M Mitsuguro","year":"2015","unstructured":"Mitsuguro M, Okamoto A, Shironouchi Y, Sano M, Miyata S, Neki R, et al. Effects of factor VIII levels on the APTT and anti-Xa activity under a therapeutic dose of heparin. Int J Hematol. 2015;101:119\u201325.","journal-title":"Int J Hematol"},{"key":"2712_CR13","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1055\/s-0037-1612949","volume":"87","author":"SD Chunilal","year":"2002","unstructured":"Chunilal SD, Young E, Johnston MA, Robertson C, Naguit I, Stevens P, et al. The APTT response of pregnant plasma to unfractionated heparin. Thromb Haemost. 2002;87:92\u20137.","journal-title":"Thromb Haemost"},{"key":"2712_CR14","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1182\/blood-2016-03-703728","volume":"128","author":"A Gerhardt","year":"2016","unstructured":"Gerhardt A, Scharf RE, Greer IA, Zotz RB. Hereditary risk factors for thrombophilia and probability of venous thromboembolism during pregnancy and the puerperium. Blood. 2016;128:2343\u20139.","journal-title":"Blood"},{"key":"2712_CR15","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/AOG.0000000000001347","volume":"127","author":"M Rheaume","year":"2016","unstructured":"Rheaume M, Weber F, Durand M, Mahone M. Pregnancy-related venous thromboembolism risk in asymptomatic women with antithrombin deficiency: a systematic review. Obstet Gynecol. 2016;127:649\u201356.","journal-title":"Obstet Gynecol"},{"key":"2712_CR16","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.transci.2018.04.010","volume":"57","author":"J Amiral","year":"2018","unstructured":"Amiral J, Seghatchian J. Revisiting antithrombin in health and disease, congenital deficiencies and genetic variants, and laboratory studies on alpha and beta forms. Transfus Apher Sci. 2018;57:291\u20137.","journal-title":"Transfus Apher Sci"},{"key":"2712_CR17","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/0049-3848(76)90034-7","volume":"8","author":"AN Teien","year":"1976","unstructured":"Teien AN, Lie M, Abildgaard U. Assay of heparin in plasma using a chromogenic substrate for activated factor X. Thromb Res. 1976;8:413\u20136.","journal-title":"Thromb Res"},{"key":"2712_CR18","first-page":"1013","volume-title":"Williams Obstetrics","author":"FG Cunningham","year":"2009","unstructured":"Cunningham FG, Leveno K, Bloom S, Hauth J, Rouse D, Spong C. Thromboembolic disorders. In: Fried A, Davis K, editors. Williams Obstetrics. 23rd ed. New York: McGraw Hill; 2009. p. 1013\u201332.","edition":"23"},{"key":"2712_CR19","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4:295\u2013306.","journal-title":"J Thromb Haemost"},{"key":"2712_CR20","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"S Schulman","year":"2005","unstructured":"Schulman S, Kearon C, Subcommittee on Control of Anticoagulation of the Scientific Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005;3:692\u20134.","journal-title":"J Thromb Haemost"},{"key":"2712_CR21","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1160\/TH13-01-0077","volume":"110","author":"K Bramham","year":"2013","unstructured":"Bramham K, Retter A, Robinson SE, Mitchell M, Moore GW, Hunt BJ. How I treat heterozygous hereditary antithrombin deficiency in pregnancy. Thromb Haemost. 2013;110:550\u20139.","journal-title":"Thromb Haemost"},{"key":"2712_CR22","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00277-013-1892-0","volume":"93","author":"N Rogenhofer","year":"2014","unstructured":"Rogenhofer N, Bohlmann MK, Beuter-Winkler P, Wurfel W, Rank A, Thaler CJ, et al. Prevention, management and extent of adverse pregnancy outcomes in women with hereditary antithrombin deficiency. Ann Hematol. 2014;93:385\u201392.","journal-title":"Ann Hematol"},{"key":"2712_CR23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.thromres.2017.05.017","volume":"157","author":"AH James","year":"2017","unstructured":"James AH, Bates SM, Bauer KA, Branch W, Mann K, Paidas M, et al. Management of hereditary antithrombin deficiency in pregnancy. Thromb Res. 2017;157:41\u20135.","journal-title":"Thromb Res"},{"key":"2712_CR24","first-page":"9261351","volume":"2017","author":"M Refaei","year":"2017","unstructured":"Refaei M, Xing L, Lim W, Crowther M, Boonyawat K. Management of venous thromboembolism in patients with hereditary antithrombin deficiency and pregnancy: case report and review of the literature. Case Rep Hematol. 2017;2017:9261351.","journal-title":"Case Rep Hematol"},{"key":"2712_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13023-014-0223-4","volume":"10","author":"TA Sagban","year":"2015","unstructured":"Sagban TA, Scharf RE, Wagenhauser MU, Oberhuber A, Schelzig H, Grabitz K, et al. Elevated risk of thrombophilia in agenesis of the vena cava as a factor for deep vein thrombosis. Orphanet J Rare Dis. 2015;10:3.","journal-title":"Orphanet J Rare Dis"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-019-02712-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-019-02712-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-019-02712-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T23:33:52Z","timestamp":1595547232000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-019-02712-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,25]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["2712"],"URL":"https:\/\/doi.org\/10.1007\/s12185-019-02712-z","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"type":"print","value":"0925-5710"},{"type":"electronic","value":"1865-3774"}],"subject":[],"published":{"date-parts":[[2019,7,25]]},"assertion":[{"value":"22 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}